Your browser doesn't support javascript.
loading
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.
Lu, Yen-Shen; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Cardoso, Fatima; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Villanueva Vazquez, Rafael; Jung, Kyung Hae; Babu, K Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; O'Regan, Ruth; Gasch, Claudia; Solovieff, Nadia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Ji, Yan; Tripathy, Debu.
Afiliação
  • Lu YS; Department of Oncology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
  • Im SA; Seoul National University Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Colleoni M; Division of Medical Senology, European Institute of Oncology (IEO), IRCCS, Milan, Italy.
  • Franke F; Hospital de Caridade de Ijuí, CACON, Ijuí, Brazil.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Cardoso F; Breast Unit, Champalimaud Foundation/Clinical Center, Lisbon, Portugal.
  • Harbeck N; Breast Center, Department of Obstetrics and Gynecology, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Hurvitz S; UCLA Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, California.
  • Chow L; Organisation for Oncology and Translational Research, Hong Kong.
  • Sohn J; Severance Hospital of Yonsei University Health System, Seoul, Republic of Korea.
  • Lee KS; Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.
  • Campos-Gomez S; Centro Oncológico Estatal, Instituto de Seguridad Social del Estado de México y Municipios, Toluca, Mexico.
  • Villanueva Vazquez R; Institut Català d'Oncologia, Hospital Moisès Broggi, Barcelona, Spain.
  • Jung KH; Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Babu KG; HCG Curie Centre of Oncology and Kidwai Memorial Institute of Oncology, Bangalore, India.
  • Wheatley-Price P; University of Ottawa, Ottawa, Ontario, Canada.
  • De Laurentiis M; Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples, Italy.
  • Im YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kuemmel S; Breast Unit, Kliniken Essen-Mitte, Essen, Germany.
  • El-Saghir N; Department of Gynecology with Breast Center, Charité - Universitätsmedizin Berlin, Germany.
  • O'Regan R; American University of Beirut Medical Center, Beirut, Lebanon.
  • Gasch C; Carbone Cancer Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin.
  • Solovieff N; Novartis Ireland Limited, Dublin, Ireland.
  • Wang C; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts.
  • Wang Y; Novartis Pharma AG, Basel, Switzerland.
  • Chakravartty A; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Ji Y; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
  • Tripathy D; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.
Clin Cancer Res ; 28(5): 851-859, 2022 Mar 01.
Article em En | MEDLINE | ID: mdl-34965945

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Clinical_trials / Guideline Limite: Female / Humans Idioma: En Revista: Clin Cancer Res Assunto da revista: NEOPLASIAS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Taiwan